CLONAZEPAM TAB,ORAL DISINTEGRATING
Clinical Criteria Summary
Continuity of Care Inclusion Criteria
- Veteran is transitioning care from the Department of Defense to VHA
- Additional Inclusion Criteria (Select ONE if appropriate)
- The medication is safe and clinically appropriate as determined by a VA prescriber using shared decision making.
- The medication is indicated for tapering the dose or slowly discontinuing therapy as determined by a VA prescriber using shared decision making.
Non-Continuity of Care Inclusion Criteria
- Difficulty swallowing oral tablet.